Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist
- 1 May 1995
- journal article
- Published by Elsevier in Life Sciences
- Vol. 56 (23-24) , 1941-1947
- https://doi.org/10.1016/0024-3205(95)00174-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Cannabinoid‐receptor expression in human leukocytesEuropean Journal of Biochemistry, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Phenylethanolaminotetralines compete with [3H]dihydroalprenolol binding to rat colon membranes without evidencing atypical β-adrenergic sitesBiochemical Pharmacology, 1992
- Molecular cloning of a human cannabinoid receptor which is also expressed in testisBiochemical Journal, 1991
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990
- GABA‐like Actions of LevonantradolThe Journal of Clinical Pharmacology, 1981
- Effects of neurotoxins (veratridine, sea anemone toxin, tetrodotoxin) on transmitter accumulation and release by nerve terminals in vitroBiochemistry, 1977
- The ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in miceBritish Journal of Pharmacology, 1972